A possible mechanism for the increase in serum luteinizing hormone levels in male rats by oxolinic acid.
Oxolinic acid (1-ethyl-1,4-dihydro-6,7-methylenedioxy-4-oxo-3- quinolinecarboxylic acid), an antimicrobial agent, raises the serum levels of luteinizing hormone (LH) and increases the incidence of testicular Leydig cell tumors in male rats. In the present study the mechanism by which serum LH levels are raised in male rats receiving oxolinic acid was investigated. Aged Wistar rats were fed a diet containing oxolinic acid at 0 or 3000 ppm for more than 4 weeks. There was no effect of oxolinic acid on either the maximal levels of serum LH after castration nor on the serum levels of LH stimulated with 1 microgram/rat of luteinizing hormone-releasing hormone (LHRH). The concentrations of testosterone in serum and testis were not changed by the treatment of oxolinic acid. In the in vitro organ culture, the testes of rats receiving oxolinic acid released testosterone in the same manner as the controls, in the presence or the absence of human chorionic gonadotropin (100 mIU/ml). The oxolinic acid-stimulated serum LH was not increased further by the daily administration of L-dopa (500 mg/kg/day, po, 7 days) and was blocked by the injection of a dopamine antagonist, haloperidol (2 mg/kg, ip). In a microdialysis study, oxolinic acid increased the extracellular concentration of dopamine in the preoptic area of hypothalamus. These findings suggest that a high dietary level of oxolinic acid elevates LH release from the anterior pituitary with an increase in LHRH, in part, by the excitatory input of a dopaminergic system in the preoptic area of rat hypothalamus.
Yamada
T
T
Environmental Health Science Laboratory, Sumitomo Chemical Company, Ltd., Osaka, Japan.
Nakamura
J
J
Okuno
Y
Y
Hosokawa
S
S
Matsuo
M
M
Yamada
H
H
Ohta
M
M
D000818:Animals; D046508:Culture Techniques; D004298:Dopamine / Q000378:metabolism; D004347:Drug Interactions; D007987:Gonadotropin-Releasing Hormone / Q000097:blood; D007031:Hypothalamus / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D007980:Levodopa / Q000494:pharmacology; D007986:Luteinizing Hormone / Q000097:blood*; D008297:Male; D009919:Orchiectomy; D010093:Oxolinic Acid / Q000633:toxicity*; D051381:Rats; D017208:Rats, Wistar; D013737:Testis / Q000187:drug effects* / Q000378:metabolism; D013739:Testosterone / Q000378:metabolism*
D007987:Gonadotropin-Releasing Hormone; D013739:Testosterone; D007980:Levodopa; D007986:Luteinizing Hormone; D010093:Oxolinic Acid; D004298:Dopamine